Companies/NuGen Medical Devices Inc.

Company profile

NuGen Medical Devices Inc.

OTC: NGMDF · Healthcare · Medical - Devices

Canadian filerHQ Toronto, ONReports USD

#995 of 1,394 Healthcare companies by revenuebottom-quartile growth

EA Score

24D

FH 20DQ —GM 38SS 23

v0.1 · 45/100 weight · provisional

↑ 3-yr revenue growth, disclosure history · ↓ listing tenure, revenue growth (YoY)

Methodology →

Revenue TTM

$119.6k

Rev growth YoY (TTM)

-84.7%

Net income (FY)

-$5.6M

Employees

Market cap

$3.6M

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$184.4k257.7k CAD2025

Net income-$5.6M-7.8M CAD2025

Operating income-$3.0M-4.2M CAD2025

Total assets$3.1M4.3M CAD2025

Liabilities$13.1M18.0M CAD2025

Equity-$10.0M-13.7M CAD2025

Revenue trend

FY2018 – FY2025 · USD

FY18

FY19

$35.3k

FY20

$109.8k

FY21

$117.1k

FY22

$245.5k

FY23

$737.2k

FY24

$184.4k

FY25

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

NuGen Medical Devices Inc. booked $184.4k in FY2025 revenue, contracting 75% year over year — slower than 87% of Healthcare companies we track, at a -3034.0% net margin.

Peers · Healthcare

ENDRA Life Sciences Inc.26D Enzolytics Inc.——Matinas BioPharma Holdings, Inc.32D Avricore Health Inc.——

Key facts

CEOLin Liang

SectorHealthcare

IndustryMedical - Devices

HeadquartersToronto, ON

ExchangeOTC: NGMDF

Employees5

IPO date2022-02-25

Latest filings

No filings loaded — no CIK (non-SEC filer).

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.